SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-21-060361
Filing Date
2021-10-13
Accepted
2021-10-13 16:19:38
Documents
1
Period of Report
2021-10-12

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3008
  Complete submission text file 0001209191-21-060361.txt   4474
Mailing Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116
Business Address 200 CLARENDON STREET FLOOR 6 BOSTON MA 02116 617-482-2333
Adicet Bio, Inc. (Issuer) CIK: 0001720580 (see all company filings)

IRS No.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O ADICET BIO, INC. 200 CLARENDON STREET, FLOOR 6 BOSTON MA 02116
Business Address
Aftab Blake (Reporting) CIK: 0001886986 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38359 | Film No.: 211321402